Complications of low-dose heparin prophylaxis in gynecologic oncology surgery.

Published

Journal Article

The clinical and laboratory effects of low-dose heparin prophylaxis was prospectively studied in a controlled trial of 182 patients undergoing major surgery for gynecologic malignancy. Low-dose heparin was given in 5000 U subcutaneously two hours preoperatively and every 12 hours for seven days postoperatively. Low-dose heparin-treated patients had a significantly increased daily retroperitoneal hemovac drainage. Although not statistically significant, low-dose heparin was associated with increased estimated intraoperative blood loss, transfusion requirements, and wound hematomas. Fifteen percent of patients receiving low-dose heparin were found to have an activated partial thromboplastin time greater than 1.5 times the control value. In these patients, all clinical bleeding parameters were significantly increased. Low-dose heparin-treated patients also had significantly prolonged activated partial thromboplastin time and lower final platelet counts as compared with the control patients. When using low-dose heparin for thromboembolism prophylaxis, patients should be closely observed for clinical hemorrhagic complications. Activated partial thromboplastin times and platelet counts should be monitored throughout therapy.

Full Text

Duke Authors

Cited Authors

  • Clarke-Pearson, DL; DeLong, ER; Synan, IS; Creasman, WT

Published Date

  • November 1, 1984

Published In

Volume / Issue

  • 64 / 5

Start / End Page

  • 689 - 694

PubMed ID

  • 6493660

Pubmed Central ID

  • 6493660

International Standard Serial Number (ISSN)

  • 0029-7844

Language

  • eng

Conference Location

  • United States